ReShape Lifesciences Inc. RSLS
3.92 0.00 (+0.00%)
At closeAug 14, 2025, 4:00 PM EDT
2.80 Day range 4.65
7.48 52-week range 1,660.09
- YTD
- -99.12%
- 1 year
- -99.62%
RSLS revenue history
Revenue is income from the company’s ordinary business activities.
8,006,000 USD
FY 2024 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | 8,006,000 | -672,000 | -7.74% |
| FY 2023 | 2023-12-31 | 8,678,000 | -2,562,000 | -22.79% |
| FY 2022 | 2022-12-31 | 11,240,000 | -2,360,000 | -17.35% |
| FY 2021 | 2021-12-31 | 13,600,000 | 2,301,000 | 20.36% |
| FY 2020 | 2020-12-31 | 11,299,000 | 8,018,000 | 244.38% |
| FY 2019 | 2019-12-31 | 3,281,000 | -5,820,000 | -63.95% |
| FY 2018 | 2018-12-31 | 9,101,000 | -813,000 | -8.20% |
| FY 2017 | 2017-12-31 | 9,914,000 | 6,521,000 | 192.19% |
| FY 2016 | 2016-12-31 | 3,393,000 | -646,000 | -15.99% |
| FY 2015 | 2015-12-31 | 4,039,000 | 500,000 | 14.13% |
| FY 2014 | 2014-12-31 | 3,539,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-08-15T15:33:39.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.